PUBLISHED FOR OPPOSITION
on 19 Nov 2024
Last Applicant/ Owned by
1616 Eastlake Avenue East, Suite 400
Seattle
WA
98102
Serial Number
98109241 filed on 31st Jul 2023
Registration Number
N/A
Correspondent Address
Lee J. Eulgen
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
AAHI
Medical and scientific research in the fields of vaccines, pharmaceuticals, biologics, vaccines, adjuvants for use with vaccines, biologic preparations, drug delivery agents, diagnostics, and medical therapeutics; product research and development in the fields of pharmaceuticals, vaccines, diagnostics, adjuvants, adjuvant formulations, biologic preparations and drug delivery agents
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Medical and scientific research in the fields of vaccines, pharmaceuticals, biologics, vaccines, adjuvants for use with vaccines, biologic preparations, drug delivery agents, diagnostics, and medical therapeutics; product research and development in the fields of pharmaceuticals, vaccines, diagnostics, adjuvants, adjuvant formulations, biologic preparations and drug delivery agents
First Use Date in General
02th Mar 2022
First Use Date in Commerce
02th Mar 2022
Mark Details
Serial Number
No 98109241
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 19th Nov 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th Nov 2024 | PUBLISHED FOR OPPOSITION |
| 13th Nov 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 10th Oct 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 24th Sep 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 24th Sep 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 24th Sep 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 26th Jun 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| 26th Jun 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 04th Apr 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |